The Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients With Diabetes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients With Diabetes

Published:2015-08-19 Issue:3 Volume:18 Page:200-206
ISSN:1524-6175
Container-title:The Journal of Clinical Hypertension
language:en
Short-container-title:J Clin Hypertens

Author:

Padwal Raj¹²,Lin Mu³⁴,Eurich Dean T.²³⁴

Affiliation:

1. Department of Medicine; University of Alberta; Edmonton AB Canada

2. Alberta Diabetes Institute; Edmonton AB Canada

3. Department of Public Health Sciences; School of Public Health; University of Alberta; Edmonton AB Canada

4. Alliance for Canadian Health Outcomes Research in Diabetes; University of Alberta; Edmonton AB Canada

Funder

Canadian Diabetes Association

Canadian Institutes of Health Research

Alberta Innovates Health Solution

Government of Alberta

University of Alberta

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jch.12647/fullpdf

Reference40 articles.

1. Trends in antihypertensive medication use and blood pressure control among United States adults with hypertension: the National Health And Nutrition Examination survey, 2001 to 2010;Gu;Circulation,2012

2. Canadian provincial trends in antihypertensive drug prescriptions between 1996 and 2006;Walker;Can J Cardiol,2011

3. 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension;ESH/ESC Task Force for the Management of Arterial Hypertension;J Hypertens,2013

4. The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension;Dasgupta;Can J Cardiol,2014

5. Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158,998 patients;Vark;Eur Heart J,2012

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiorenal Effects of Angiotensin-converting enzyme inhibitors and Angiotensin receptor blockers in people underrepresented in trials: analysis of routinely collected data with validation against a target trial;2022-12-03

2. Effectiveness of angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers on total and cardiovascular mortality and morbidity in primary prevention: A nationwide study based on French Health Insurance Data (SNDS);The Journal of Clinical Hypertension;2022-03

3. Comparative effectiveness of ACE inhibitors and angiotensin receptor blockers in patients with prior myocardial infarction;Open Heart;2019-05

4. Design of Agricultural Products Intelligent Transportation Logistics Freight Forecasting System Based on Large Data Analysis;Lecture Notes of the Institute for Computer Sciences, Social Informatics and Telecommunications Engineering;2019

5. Metabolic Syndrome as a Multifaceted Risk Factor for Oxidative Stress;Antioxidants & Redox Signaling;2017-03-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3